Cullinan Therapeutics, Inc. reports

Company 1 identity field
Location
Cambridge, MA
SEC filing record 1 source field
Fiscal year end
31 December
Cullinan Therapeutics, Inc. has filed 438 SEC EDGAR filings since 02 Nov 2020

SEC filing history

Showing 26-28 of 28 matching filings.

Per page
25
Current page
2
SC 13G/A File 005-91966

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date
20 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91966

SC 13G filing

Filing date
08 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91966

SC 13G

Filing date
15 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .